A technology for the application of defoamers in the production of biosurfactants by microbial fermentation

By adding 0.6% of the defoamer polydimethylsiloxane emulsion during the fermentation of Bacillus subtilis, the problem of foam control was solved, the yield and concentration of sodium lipopeptide were increased, the fermentation process was optimized, and a theoretical basis was provided for the industrial production of biosurfactants.

CN123063485APending Publication Date: 2026-11-10EAST CHINA UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510589180.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-08
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

In the process of producing biosurfactants by microbial fermentation, it is difficult to maintain the foam control at the optimal level, which leads to problems such as a decrease in the effective loading volume of the fermenter, liquid escape and system contamination. At the same time, the function of bubbles as gas-liquid mass transfer carriers is weakened, and the dissolved oxygen level is difficult to meet the requirements of high-density fermentation.

Method used

By adding different concentrations of polydimethylsiloxane emulsion as an antifoaming agent during the fermentation of Bacillus subtilis, the amount of foam was optimized, and the optimal concentration of the antifoaming agent was determined to be 0.6% to promote cell growth and increase product concentration.

Benefits of technology

Without affecting cell growth, the yield and concentration of sodium lipopeptide were significantly increased, the fermentation process was optimized, and guidance for the industrial production of the biosurfactant sodium lipopeptide was provided.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005392679560000041
    Figure BDA0005392679560000041
  • Figure BDA0005392679560000042
    Figure BDA0005392679560000042
  • Figure BDA0005392679560000051
    Figure BDA0005392679560000051
Patent Text Reader

Abstract

This application relates to an application technology of defoaming agents in the microbial fermentation production of biosurfactants. Based on the production of sodium lipopeptide from Bacillus subtilis, different concentrations of polydimethylsiloxane emulsion were added to the fermentation medium as defoaming agents, and the mixture was cultured at 200 rpm and 37°C for 48 h. After the culture, the biomass and crude sodium lipopeptide content of each fermentation broth were determined by high-performance liquid chromatography (HPLC). The results showed that when the amount of defoaming agent added was 0.6%, both the biomass accumulation of Bacillus subtilis and the synthesis yield of sodium lipopeptide reached the optimal level, resulting in the best overall benefit. This study further confirms that the application technology of the defoaming agent polydimethylsiloxane significantly affects the product yield and purity in the fermentation process of sodium lipopeptide production from Bacillus subtilis, providing important technical support for optimizing the efficient preparation process of sodium lipopeptide from Bacillus subtilis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of microbial fermentation technology, specifically to an application technology for investigating the effect of defoamer dosage on cell growth and products. Background Technology

[0002] Sodium subtilis lipopeptide is an anionic lipopeptide biosurfactant produced by the fermentation of Bacillus subtilis, and is considered one of the most efficient biosurfactants available today. Its molecular structure consists of a seven-amino acid cyclic peptide hydrophilic group and a β-hydroxy fatty acid chain. The cyclic structure allows for hydrogen bonding between molecules, resulting in a critical micelle concentration (CMC) of only 0.0003% (mass fraction), one of the lowest known CMCs for surfactants. Its unique molecular structure endows it with excellent emulsifying, dispersing, and other surface activities, as well as biodegradability. Its applications cover plant disease control, antibiotic development, cosmetic research, detergent production, and oil extraction. Compared to chemically synthesized surfactants, sodium subtilis lipopeptide is less toxic, milder, more stable, and degrades rapidly in the natural environment. With increasing environmental protection demands, this type of biosurfactant derived from microbial metabolism is becoming a research hotspot in the field of green chemistry.

[0003] In the fermentation process of biosurfactants, foam control is particularly important. Foam is a dispersion system in which a large amount of gas is dispersed in a liquid, and its interfacial behavior directly affects the fermentation process: when foam accumulates excessively, it not only leads to a decrease in the effective loading volume of the fermenter, but may even cause problems such as liquid escape and system contamination; conversely, when the amount of foam is too low, the function of bubbles as gas-liquid mass transfer carriers is weakened, making it difficult to meet the dissolved oxygen level requirements of high-density fermentation. Defoamers are usually added to control foam, requiring a certain amount of foam while removing excess foam, and maintaining a long-term stable defoaming ability that does not decrease with prolonged fermentation time. Therefore, finding the optimal concentration of defoamer in the microbial fermentation production of biosurfactants, so as to keep the amount of foam in the fermentation process at an optimal level, has become a pressing technical challenge in this field. Summary of the Invention

[0004] The purpose of this invention is to explore the optimal concentration of defoamer in the microbial fermentation production of biosurfactants. The result of this invention is that the foam in the Bacillus subtilis fermentation process of sodium lipopeptide reaches an optimal state, achieving the highest yield under the same culture conditions.

[0005] To achieve the above objectives, the present invention provides the following solution:

[0006] This invention investigates the optimal defoamer concentration for maximizing bacterial growth and product concentration by adding different concentrations of defoamer. The method includes: based on the fermentation of Bacillus subtilis to produce sodium lipopeptide, a series of concentration gradients of polydimethylsiloxane emulsion as defoamer are added to the culture medium, and the mixture is incubated at 200 rpm and 37°C for 48 h. After incubation, the pH and OD of the fermentation broth are measured, and the biomass and dry weight of the crude sodium lipopeptide extract for each group are determined by weighing. The yield and purity of sodium lipopeptide are also determined by HPLC. The experimental results show that when the defoamer concentration is 0.6%, the yield of sodium lipopeptide is significantly higher than in other groups.

[0007] In summary, the present invention discloses the following technical effects:

[0008] Using polydimethylsiloxane emulsion as an antifoaming agent, at a concentration of 0.6%, this invention had no negative impact on bacterial growth during fermentation. Furthermore, it significantly promoted the synthesis of the fermentation product, sodium lipopeptide, and substantially increased the product concentration. This research is of great significance for optimizing the efficient preparation process of sodium lipopeptide fermented by Bacillus subtilis, providing a theoretical basis and industrial application guidance for the industrial production of the biosurfactant sodium lipopeptide. Attached Figure Description

[0009] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0010] Figure 1 The effect of different concentrations of defoamer on OD;

[0011] Figure 2 The effect of different concentrations of defoamer on sodium lipopeptide content;

[0012] Figure 3 The effect of different concentrations of defoamer on the content of crude sodium lipopeptide extract;

[0013] Figure 4 The effect of different concentrations of defoamer on pH;

[0014] Figure 5 HPLC chromatogram of fermentation broth with 0% defoamer concentration

[0015] Figure 6 HPLC chromatogram of fermentation broth with 0.1% defoamer concentration

[0016] Figure 7 HPLC chromatogram of fermentation broth with 0.2% defoamer concentration

[0017] Figure 8 HPLC chromatogram of fermentation broth with 0.4% defoamer concentration

[0018] Figure 9 HPLC chromatogram of fermentation broth with 0.6% defoamer concentration

[0019] Figure 10 HPLC chromatogram of fermentation broth with 0.8% defoamer concentration

[0020] Figure 11 HPLC chromatogram of fermentation broth with 1.0% defoamer concentration

[0021] Figure 12 HPLC chromatogram of fermentation broth with 1.3% defoamer concentration Detailed Implementation

[0022] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0023] It should be understood that the terminology used in this invention is merely for describing particular embodiments and is not intended to limit the invention. Furthermore, with respect to numerical ranges in this invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Any stated value or intermediate value within a stated range, as well as each smaller range between any other stated value or intermediate value within said range, is also included in this invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.

[0024] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. While only preferred methods and materials have been described herein, any methods and materials similar or equivalent to those described herein may be used in the implementation or testing of this invention. All references to this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.

[0025] Various modifications and variations can be made to the specific embodiments described in this specification without departing from the scope or spirit of the invention, as will be apparent to those skilled in the art. Other embodiments derived from this specification will also be readily apparent to those skilled in the art. This specification and embodiments are merely exemplary.

[0026] The terms “include,” “including,” “have,” “contain,” etc., used in this article are all open-ended terms, meaning that they include but are not limited to.

[0027] The present invention will be further illustrated below with reference to specific embodiments. It should be understood that these embodiments are for illustrative purposes only and are not intended to limit the scope of the invention.

[0028] The materials and methods used in the following embodiments generally include:

[0029] 1.1 Materials

[0030] 1.1.1 Bacillus subtilis

[0031] 1.1.2 Seed bottle culture medium

[0032] Glucose 20g / L, L-glutamic acid 5g / L, magnesium sulfate 0.5g / L, potassium chloride 0.5g / L, potassium dihydrogen phosphate 1g / L, ferrous sulfate heptahydrate 0.3g / L, manganese sulfate 1.69mg / L, copper sulfate pentahydrate 0.16mg / L, yeast extract 1g / L, pH 7.0-7.2, sterilized at 0.1MPa for 20 minutes.

[0033] Before adjusting the pH, the culture medium pH was approximately 3.6. The pH was adjusted to approximately 6 using 6 mol of sodium hydroxide, and then adjusted to 7.0-7.2 using 1 mol of sodium hydroxide.

[0034] 1.1.3 Fermentation medium

[0035] Magnesium sulfate 0.5 g / L, potassium chloride 0.5 g / L, potassium dihydrogen phosphate 1 g / L, ferrous sulfate heptahydrate 0.3 g / L, manganese sulfate 1.69 mg / L, copper sulfate pentahydrate 0.16 mg / L, yeast extract 1 g / L, ammonium sulfate 2 g / L, sucrose 30 g / L, soluble starch 50 g / L, L-glutamate sodium 20 g / L.

[0036] 1.2 Methods

[0037] 1.2.1 Starch gelatinization

[0038] Weigh the starch separately, then add an appropriate amount of room temperature deionized water to make a dilute solution. In a stainless steel pot, add an appropriate amount of deionized water (less than the volume required to prepare the culture medium solution) and bring to a boil. Continuously add the diluted starch solution while stirring the solution in the pot until it becomes transparent.

[0039] Mix the gelatinized starch with the weighed other reagents, bring the volume to the required level, then adjust the pH to 7.0-7.2 and sterilize at 0.1 MPa for 30 minutes.

[0040] Before adjusting the pH, the culture medium pH was approximately 3.6. The pH was adjusted to approximately 6 using 6 mol of sodium hydroxide, and then adjusted to 7.0-7.2 using 1 mol of sodium hydroxide.

[0041] Defoamer and monosodium glutamate are added directly to the culture medium for sterilization.

[0042] 1.2.2 Seed Culture

[0043] The preserved glycerol tube (2018 strain) was inoculated at 1% into 50 mL of seed culture medium (50 mL of liquid in a 500 mL Erlenmeyer flask). Two flasks were inoculated and cultured at 200 rpm and 33 °C for 24 h.

[0044] 1.2.3 Shaking Flask Fermentation

[0045] Inoculate 3% of the seed culture into 50 mL of fermentation medium (100 mL in a 500 mL Erlenmeyer flask). Inoculate 2 flasks per group and incubate at 200 rpm and 37 °C for 48 h.

[0046] 1.2.4 Sample processing of fermentation broth and determination of crude sodium lipopeptide

[0047] After fermentation, the two parallel groups were mixed, and 40 mL of fermentation broth from each group was transferred to a 50 mL centrifuge tube (pre-weighed empty centrifuge tube). Two parallel samples were centrifuged at 9000 rpm and 10℃ for 30 min. After centrifugation, the supernatant was transferred to a centrifuge tube (pre-weighed empty centrifuge tube). The centrifuge tube containing the supernatant and residual cells was placed in a 60℃ oven and dried for 48 h. The dry weight biomass was then calculated.

[0048]

[0049] In the formula: X -------dry weight biomass content (g / L)

[0050] W2--------Dry weight plus centrifuge tube weight (g)

[0051] W1-------Centrifuge tube weight (g)

[0052] 0.040 ------- Fermentation broth volume (40 mL)

[0053] Mix 30 mL of supernatant with deionized water at a volume ratio of 4:1. Adjust the pH of the supernatant to approximately 4.0 with 6 mol / L hydrochloric acid. Let the acidified solution stand at 4℃ for 12-24 h. Then centrifuge the acidified solution at 9000 rpm at 10℃ for 30 min, discard the supernatant, and dry the centrifuge tubes in a 60℃ oven for 72 h. Weigh and calculate the crude sodium lipopeptide extract.

[0054] Calculation of crude lipopeptide sodium extract:

[0055]

[0056] In the formula: Y ------- content of crude sodium lipopeptide extract (g / L)

[0057] W2--------Dry weight of sodium lipopeptide crude extract plus centrifuge tube weight (g)

[0058] W1-------Centrifuge tube weight (g)

[0059] 0.030-------Volume of fermentation supernatant (30 mL)

[0060] Implementation Example 1: HPLC Determination Method

[0061] Detection conditions: Wavelength 205 nm; injection volume 20 μL; column pressure 6.0 MPa; flow rate 1 mL / min; detection time 40 min. Mobile phase: 20% 3.8 mM trifluoroacetic acid (TFA) + 80% acetonitrile, mixed, filtered through a 0.45 μm organic filter membrane, sonicated for 15 min, and allowed to return to room temperature (Note: 0.293 mM TFA was added to 1 L of pure water and filtered through a 0.45 μm water film to prepare a 3.8 mmol / L TFA aqueous solution); Column: Kromasil 5 μC18, 200 × 4.6 mm, column temperature 30 ℃. Fermentation broth sample preparation: Centrifuged at 9000 rpm, 20 ℃, for 25 min, and 1.0 mL of the supernatant was added to 9.0 mL of distilled water for dilution. Filtration: The diluted and mixed sample was filtered through a 0.22 μm water-soluble microporous membrane, and the filtrate was collected in a 10.0 mL centrifuge tube. If samples cannot be tested immediately, seal them with sealing film and store them in a 4°C refrigerator until testing. Solid sample or standard preparation: Crush solid samples, weigh 50 mg of sample and dissolve it in 25 mL of mobile phase (acetonitrile: 3.8 mmol TFA water at a 4:1 ratio), sonicate for 15 min at 20°C with an ultrasonic intensity of level 4; Filtration: Filter the diluted and mixed sample through a 0.22 μm organic microporous membrane and collect the filtrate in a 10.0 mL centrifuge tube. If samples cannot be tested immediately, seal them with sealing film and store them in a 4°C refrigerator until testing.

[0062] Surfactin from Sigma was used as a standard sample, and samples were serially diluted to generate a standard curve.

[0063] Experimental Results and Analysis of Fermentation in Example 2

[0064]

[0065]

[0066] Effect of defoamer dosage on pH: Data shows that the pH values ​​of different experimental groups fluctuated between 7.92 and 8.22. The overall fluctuation range was relatively small, indicating that the amount of defoamer added did not have a significant effect on the pH value of the fermentation broth. However, as the amount of defoamer added increased from 0 to 0.2%, the pH value showed an upward trend, followed by a decrease. This may suggest that within a certain range, the addition of defoamer can affect the acid-base balance of the fermentation system, but beyond a certain threshold, this effect becomes more complex.

[0067] The effect of defoamer dosage on OD value: OD value usually reflects the growth density of microorganisms. The OD value initially decreases with increasing defoamer dosage, reaching a minimum of 15.36 at a dosage of 0.2%, and then increases again. This may indicate that an appropriate amount of defoamer (e.g., 0.2%) has a certain inhibitory effect on microbial growth, but as the dosage continues to increase, the microorganisms may gradually adapt to the environment, and the growth density recovers.

[0068] Effects of defoamer dosage on the crude extract and content of sodium lipopeptide: The crude extract and content of sodium lipopeptide initially increased with increasing defoamer dosage, reaching 33.74 g / L and 11.09 g / L respectively when the defoamer dosage was 0.6%, after which they decreased. This indicates that an appropriate amount of defoamer can promote the synthesis of sodium lipopeptide, but excessive defoamer may inhibit its synthesis.

[0069] Effect of defoamer dosage on product purity: Product purity reached its highest value of 0.76 when the defoamer dosage was 0.4%, and then decreased. This indicates that increasing the amount of defoamer can improve product purity within a certain range, but excessive addition will lead to a decrease in purity, possibly because too much defoamer introduces impurities or affects the separation and purification process of the product.

[0070] Adding different concentrations of defoamer to the culture medium had little effect on bacterial growth. However, the experimental groups with added defoamer had higher sodium lipopeptide content than the control group. It is speculated that this may be because the defoamer is a silane-like substance that the strain can use to synthesize cyclic lipopeptides. However, adding defoamer also affected the purity, dry weight biomass, and crude extract of the product.

[0071] Taking into account factors such as biomass, product synthesis, and purity, a defoamer concentration of 0.6% shows the best performance in promoting biomass accumulation and product synthesis. Although the product purity is not the highest at this concentration, the overall benefits are relatively good. Therefore, the optimal defoamer concentration is speculated to be 0.6%.

[0072] The applicant declares that the present invention illustrates, through the above embodiments, a method for optimizing the concentration of defoamer in the microbial fermentation production of biosurfactants, but the present invention is not limited to the above embodiments, that is, it does not mean that the present invention must rely on the above embodiments to be implemented. Those skilled in the art should understand that any improvements to the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

[0073] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Various modifications and improvements made by those skilled in the art to the technical solutions of the present invention without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.

Claims

1. An optimal concentration of an antifoaming agent based on the production of biosurfactants through microbial fermentation, characterized in that, Includes the following steps: S1. Using the shake-flask fermentation method, 3% seed liquid was inoculated into 50mL of fermentation medium, and fermentation was carried out under a series of antifoaming agents of varying concentrations to obtain a fermentation broth for 48 hours. S2. The biomass of each fermentation broth and the dry weight of the crude sodium lipopeptide product are obtained by drying and weighing the fermentation broth. S3. Using HPLC based on liquid chromatography analysis, the precise content and purity of sodium lipopeptide in each group of fermentation broth were obtained. Comprehensive analysis showed that the optimal concentration of defoamer for the production of biosurfactants by microbial fermentation was 6%.

2. The optimal concentration of the defoamer based on microbial fermentation for producing biosurfactants according to claim 1, characterized in that, In step S1, Bacillus subtilis is cultured in shake flasks. The Bacillus subtilis seed culture is inoculated into 50 mL of fermentation medium at a rate of 3%. Two flasks are inoculated per group, and the culture is carried out at 200 rpm and 37°C for 48 h to obtain the fermentation broth.

3. The optimal concentration of the defoamer based on the microbial fermentation production of biosurfactants according to claim 1, characterized in that, In step S2, the biomass of the fermentation broth and the dry weight of the crude sodium lipopeptide product were measured. Two parallel sets were mixed and centrifuged for 30 min. The centrifuge tubes containing the supernatant and residual cells were placed in a 60℃ oven for 48 h, and the dry weight biomass was calculated. 30 mL of supernatant was mixed with deionized water at a 4:1 volume ratio. The pH of the supernatant was adjusted to approximately 4.0 using 6 mol / L hydrochloric acid, and the acidified solution was allowed to stand at 4℃ for 12-24 h. Then, the acidified solution was centrifuged at 9000 rpm at 10℃ for 30 min. The supernatant was discarded, and the centrifuge tubes were placed in a 60℃ oven for 72 h. The dry weight of the crude sodium lipopeptide product was calculated.

4. The optimal concentration of the defoamer based on microbial fermentation for producing biosurfactants according to claim 1, characterized in that, In step S3, the content and purity of sodium lipopeptide are accurately measured. The precise content and purity of sodium lipopeptide in each fermentation broth are detected by liquid chromatography. Comprehensive analysis shows that the optimal concentration of defoamer for the production of biosurfactants by microbial fermentation is 6%.